Cargando…
Commentary: Bettering BCG: a tough task for a TB vaccine?
Autores principales: | Srivastava, Brahm S., Singh, Vipul K., Kashyap, Vivek K., Srivastava, Ranjana, Khan, Arshad, Jagannath, Chinnaswamy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752056/ https://www.ncbi.nlm.nih.gov/pubmed/31572397 http://dx.doi.org/10.3389/fimmu.2019.02195 |
Ejemplares similares
-
NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice
por: Khan, Arshad, et al.
Publicado: (2020) -
GM-CSF Dependent Differential Control of Mycobacterium tuberculosis Infection in Human and Mouse Macrophages: Is Macrophage Source of GM-CSF Critical to Tuberculosis Immunity?
por: Mishra, Abhishek, et al.
Publicado: (2020) -
Human Macrophages Exhibit GM-CSF Dependent Restriction of Mycobacterium tuberculosis Infection via Regulating Their Self-Survival, Differentiation and Metabolism
por: Mishra, Abhishek, et al.
Publicado: (2022) -
Sirtuin-dependent metabolic and epigenetic regulation of macrophages during tuberculosis
por: Zhang, Kangling, et al.
Publicado: (2023) -
Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Mycobacterium tuberculosis
por: Singh, Vipul K., et al.
Publicado: (2022)